| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1439-0507.1994.TB00394.X |
| P953 | full work available at URL | http://deepblue.lib.umich.edu/bitstream/2027.42/71938/1/j.1439-0507.1994.tb00394.x.pdf |
| https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1439-0507.1994.tb00394.x | ||
| https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1439-0507.1994.tb00394.x | ||
| P698 | PubMed publication ID | 7659131 |
| P5875 | ResearchGate publication ID | 15540288 |
| P2093 | author name string | C. A. Kauffman | |
| S. F. Bradley | |||
| G. P. Prokopowicz | |||
| P2860 | cites work | Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies | Q33898647 |
| Hydroxamate siderophore production by opportunistic and systemic fungal pathogens | Q36348829 | ||
| Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry | Q37559395 | ||
| Disseminated infection caused by Cunninghamella bertholletiae in a patient with beta-thalassemia. Case report and review of the literature | Q38381777 | ||
| Zygomycosis of the basal ganglia in intravenous drug users | Q38596720 | ||
| Mucormycosis: association with deferoxamine therapy | Q38704400 | ||
| Disseminated zygomycosis: report of four cases and review | Q38717683 | ||
| Cunninghamella bertholletiae infection associated with deferoxamine therapy. | Q39550186 | ||
| Cutaneous Lesions in Disseminated Mucormycosis | Q43711133 | ||
| Cunninghamella: a newly recognized cause of rhinocerebral mucormycosis | Q44145051 | ||
| Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis). | Q44357651 | ||
| Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: epidemiology, mycology and treatment | Q44954766 | ||
| Phycomycosis complicating leukemia and lymphoma | Q48712251 | ||
| Phycomycosis of the gastrointestinal tract | Q54503565 | ||
| Mucormycosis | Q68094584 | ||
| Hospital-acquired wound mucormycosis | Q68104641 | ||
| Wound zygomycosis (mucormycosis) in otherwise healthy adults | Q68281467 | ||
| Intestinal mucormycosis in hemodialysis patients following deferoxamine | Q69105230 | ||
| Fatal Rhizopus infections in hemodialysis patients receiving deferoxamine | Q69415286 | ||
| Deferoxamine treatment as a risk factor for zygomycete infection | Q69934741 | ||
| Improved diagnosis and prognosis of mucormycosis. A clinicopathologic study of 33 cases | Q70020483 | ||
| The changing spectrum of disease, etiology, and diagnosis of mucormycosis | Q71361895 | ||
| The effect of deferoxamine on different zygomycetes | Q72695849 | ||
| Effect of ferrioxamine on the growth of Rhizopus | Q72792515 | ||
| Cutaneous mucormycosis resembling superficial granulomatous pyoderma in an immunocompetent host | Q72876150 | ||
| P433 | issue | 11-12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | zygomycosis | Q3046374 |
| deferoxamine | Q419618 | ||
| chelation therapy | Q1069061 | ||
| P304 | page(s) | 427-431 | |
| P577 | publication date | 1994-11-01 | |
| P1433 | published in | Mycoses | Q1956531 |
| P1476 | title | Indolent zygomycosis associated with deferoxamine chelation therapy | |
| P478 | volume | 37 |
| Q34428108 | Animal models of zygomycosis--Absidia, Rhizopus, Rhizomucor, and Cunninghamella |
| Q34440240 | Epidemiology and outcome of zygomycosis: a review of 929 reported cases |
| Q26859275 | Infections in myelodysplastic syndromes |
| Q64906482 | Pulmonary Mucormycosis in a Patient With Uncontrolled Diabetes. |
| Q24514527 | Zygomycetes in human disease |
Search more.